X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (155) 155
oncology (138) 138
index medicus (112) 112
female (78) 78
chemotherapy (67) 67
cancer (65) 65
middle aged (55) 55
aged (51) 51
male (44) 44
adult (39) 39
antineoplastic combined chemotherapy protocols - therapeutic use (39) 39
breast cancer (38) 38
treatment outcome (38) 38
breast neoplasms - drug therapy (35) 35
lung neoplasms - drug therapy (35) 35
survival (35) 35
prognosis (34) 34
antineoplastic agents - therapeutic use (31) 31
lung cancer (31) 31
disease-free survival (30) 30
research (30) 30
carcinoma, non-small-cell lung - drug therapy (29) 29
care and treatment (28) 28
neoplasm staging (26) 26
hematology, oncology and palliative medicine (25) 25
randomized controlled trials as topic (25) 25
respiratory system (25) 25
therapy (25) 25
survival analysis (24) 24
aged, 80 and over (22) 22
analysis (22) 22
lung neoplasms - pathology (22) 22
breast neoplasms - pathology (21) 21
review (21) 21
meta-analysis (20) 20
docetaxel (19) 19
immunotherapy (19) 19
lung neoplasms - genetics (19) 19
double-blind (18) 18
drug therapy (18) 18
metaanalysis (18) 18
metastasis (18) 18
open-label (18) 18
antineoplastic agents - adverse effects (17) 17
clinical trials (17) 17
pharmacology & pharmacy (17) 17
tumors (17) 17
carcinoma (16) 16
chemotherapy, adjuvant (16) 16
expression (16) 16
health aspects (16) 16
mutation (16) 16
phase-iii trial (16) 16
retrospective studies (16) 16
carcinoma, non-small-cell lung - pathology (15) 15
paclitaxel (15) 15
risk factors (15) 15
cell lung-cancer (14) 14
survival rate (14) 14
adenocarcinoma (13) 13
adjuvant chemotherapy (13) 13
antibodies, monoclonal - therapeutic use (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
lung cancer, non-small cell (13) 13
medicine & public health (13) 13
neoplasm metastasis (13) 13
trial (13) 13
1st-line treatment (12) 12
disease progression (12) 12
drug administration schedule (12) 12
egfr (12) 12
neoplasms. tumors. oncology. including cancer and carcinogens (12) 12
nsclc (12) 12
pathology (12) 12
angiogenesis (11) 11
angiogenesis inhibitors - therapeutic use (11) 11
biomarkers (11) 11
breast neoplasms - mortality (11) 11
carcinoma, non-small-cell lung - genetics (11) 11
hematology (11) 11
lung neoplasms - mortality (11) 11
patient outcomes (11) 11
trastuzumab (11) 11
adjuvant (10) 10
antineoplastic agents - pharmacology (10) 10
clinical-trials (10) 10
genetic aspects (10) 10
non-small cell lung cancer (10) 10
pancreatic cancer (10) 10
phase-iii (10) 10
protein kinase inhibitors - therapeutic use (10) 10
surgery (10) 10
tyrosine kinase inhibitors (10) 10
adjuvant treatment (9) 9
antibodies, monoclonal, humanized (9) 9
bevacizumab (9) 9
breast-cancer (9) 9
carcinoma, non-small-cell lung - mortality (9) 9
clinical trials as topic (9) 9
clinical trials, phase iii as topic (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, p. e0130142
Background The potential predictive role of programmed death-ligand-1 (PD-L1) expression on tumor cells in the context of solid tumor treated with checkpoint... 
CTLA-4 BLOCKADE | ANTI-PD-L1 ANTIBODY | EFFICACY | SAFETY | MULTIDISCIPLINARY SCIENCES | OPEN-LABEL | ANTITUMOR IMMUNITY | CLINICAL ACTIVITY | IPILIMUMAB | CHEMOTHERAPY | CHECKPOINT BLOCKADE | Lung Neoplasms - drug therapy | Melanoma - diagnosis | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Neoplasms - diagnosis | Urogenital System - pathology | Neoplasms - genetics | Melanoma - genetics | Urogenital Neoplasms - drug therapy | Lung - metabolism | Lung Neoplasms - genetics | Lung - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Treatment Outcome | Urogenital System - drug effects | B7-H1 Antigen - genetics | Neoplasms - drug therapy | Urogenital System - metabolism | Urogenital Neoplasms - genetics | Lung - drug effects | Melanoma - drug therapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Urogenital Neoplasms - diagnosis | Lung cancer, Non-small cell | Care and treatment | Tumors | PD-1 protein | Lung cancer | Clinical trials | Antibodies | Oncology | Cancer therapies | Confidence intervals | Immunotherapy | Sensitivity analysis | Tumor cells | Melanoma | Non-small cell lung carcinoma | Patients | Pathology | Immune checkpoint | Medical prognosis | PD-L1 protein | Response rates | Biomarkers | Ligands | Mutation | Solid tumors | Blood diseases | Cancer | Apoptosis
Journal Article
Cancer Cell, ISSN 1535-6108, 04/2016, Volume 29, Issue 4, pp. 437 - 439
In this issue of , further advance chemokine interference as a therapeutic option for cancer by demonstrating the effect of CCR5 blockade in reshaping... 
BREAST-CANCER | CELLS | ONCOLOGY | PD-1 BLOCKADE | CELL BIOLOGY | Receptors, CCR5 | Chemokine CCL5 | Colorectal Neoplasms | Humans | Soft Tissue Neoplasms | Liver cancer | Analysis | Colorectal cancer | Tumors
Journal Article
The Journal of Pathology, ISSN 0022-3417, 03/2017, Volume 241, Issue 4, pp. 488 - 500
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 09/2019, Volume 11, Issue S15, pp. S1837 - S1840
Journal Article
European Journal of Cancer Care, ISSN 0961-5423, 03/2017, Volume 26, Issue 2, pp. e12618 - n/a
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2014, Volume 17, Issue 3, pp. 442 - 449
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e80478
Journal Article
European Journal of Clinical Nutrition, ISSN 0954-3007, 05/2018, Volume 72, Issue 5, pp. 772 - 779
Journal Article
Cancers, ISSN 2072-6694, 01/2018, Volume 10, Issue 1, p. 23
The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing and integrating a variety of exogenous cues to regulate cellular growth and... 
Targeted therapies | MTORC1 | MTORC2 | Cross-talk | Cancer | MAMMALIAN TARGET | MESSENGER-RNA TRANSLATION | targeted therapies | cross-talk | RENAL-CELL CARCINOMA | PROTEIN-KINASE B | PHASE-III TRIAL | BREAST-CANCER | TUBEROUS SCLEROSIS COMPLEX | TUMOR-SUPPRESSOR COMPLEX | ONCOLOGY | HEMATOPOIETIC STEM-CELLS | cancer | mTORC2 | mTORC1 | NF-KAPPA-B | TOR protein | Cell growth | Rapamycin | Drug resistance | Metabolism | Drug therapy
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 7119 - 13
The incidence and mortality rates of intrahepatic cholangiocarcinoma have been rising worldwide. Few patients present an early-stage disease that is amenable... 
HETEROGENEITY | BILIARY-TRACT CANCER | METAANALYSIS | RECOMMENDATIONS | MULTIDISCIPLINARY SCIENCES | MUTATIONS | TUMORS | CARCINOMA | TRENDS | GENOME | Mutation
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 7_suppl, pp. 258 - 258
Journal Article